Ian Rabinowitz
University of New Mexico · 78 works · 2,320 citations · h-index 21
Top works
- Accuracy of radiation field alignment in clinical practice
- First-Line Nivolumab Plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as Biomarkers
- Adhesion receptor activation of phosphatidylinositol 3-kinase. von Willebrand factor stimulates the cytoskeletal association and activation of phosphatidylinositol 3-kinase and pp60c-src in human platelets.
- Clinicopathologic Features of Agranulocytosis in the Setting of Levamisole-Tainted Cocaine
- Molecular basis of von Willebrand disease type IIB. Candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein Ib binding sequences.
- von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib.
- Physician Compliance With Warfarin Prophylaxis for Central Venous Catheters in Patients With Solid Tumors
- Phase II, Randomized Trial to Compare Anastrozole Combined with Gefitinib or Placebo in Postmenopausal Women with Hormone Receptor–Positive Metastatic Breast Cancer
- Biomarkers, Fatigue, Sleep, and Depressive Symptoms in Women With Breast Cancer: A Pilot Study
- Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: the Axtell regimen
- A phase II multicenter, double-blind, randomized trial to compare anastrozole plus gefinitib with anastrozole plus placebo in postmenopausal women with hormone receptor-positive (HR+) metastatic breast cancer (MBC)
- Epstein–Barr virus-associated inflammatory pseudotumor of the spleen: report of two cases and review of the literature
- Enhanced Leukemia Cell Detection Using a Novel Magnetic Needle and Nanoparticles
- New variant of von Willebrand disease type II with markedly increased levels of von Willebrand factor antigen and dominant mode of inheritance: von Willebrand disease type IIC Miami
- A phase I and pharmacokinetic study of paclitaxel poliglumex and cisplatin in patients with advanced solid tumors
- Interaction Between Statins and Rituximab in Non-Hodgkin's Lymphoma
- Type IIB mutation His-505–>Asp implicates a new segment in the control of von Willebrand factor binding to platelet glycoprotein Ib.
- Anaplastic large cell lymphoma associated with breast implants.
- Amplification Patterns of Three Genomic Regions Predict Distant Recurrence in Breast Carcinoma
- Characterization of Three Mutations Causing von Willebrand Disease Type IIA in Five Unrelated Families